Pascal Deschatelets is CSO at Apellis Pharmaceuticals, Inc. (APLS). They have made 29 open-market trades across 1 company since 2019, most recently 2026-05-14.
CIK 0001657720
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 29 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APLS | 41,250 | $1.7M |
Shares reported on the most recent Form 4, priced at the 2026-05-14 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APLS | SELL | 2026-01-22 | 2026-01-23 | $21.77 | $129K | +7.2% | +4.1% | +89.6% |
| APLS | SELL | 2026-01-20 | 2026-01-21 | $19.79 | $18K | +9.0% | +6.3% | +95.4% |
| APLS | SELL | 2026-01-13 | 2026-01-15 | $22.19 | $51K | +12.4% | +5.1% | +99.0% |
| APLS | SELL | 2025-01-29 | 2025-01-30 | $29.52 | $24K | -5.8% | -20.6% | -36.6% |
| APLS | SELL | 2025-01-22 | 2025-01-23 | $30.43 | $240K | -6.4% | -10.8% | -43.1% |
| APLS | SELL | 2025-01-17 | 2025-01-21 | $29.96 | $22K | -3.4% | -5.6% | -39.9% |
| APLS | SELL | 2025-01-13 | 2025-01-14 | $28.70 | $131K | +5.2% | -3.1% | -31.8% |
| APLS | SELL · 10b5-1 | 2024-05-08 | 2024-05-09 | $42.35 | $6.7M | -0.7% | -2.7% | -21.6% |
| APLS | SELL · 10b5-1 | 2024-04-08 | 2024-04-09 | $54.17 | $7.5M | -11.5% | -20.8% | -31.1% |
| APLS | SELL · 10b5-1 | 2024-03-08 | 2024-03-11 | $62.33 | $5.9M | -6.6% | -6.3% | -31.2% |
| APLS | SELL | 2024-02-12 | 2024-02-13 | $67.77 | $156K | +7.0% | -15.8% | -35.8% |
| APLS | SELL | 2024-01-29 | 2024-01-31 | $64.14 | $112K | +6.8% | +0.7% | -30.4% |
| APLS | SELL | 2024-01-22 | 2024-01-23 | $65.00 | $254K | -6.3% | +1.3% | -28.6% |
| APLS | SELL | 2024-01-16 | 2024-01-17 | $66.81 | $218K | -1.8% | +3.3% | -22.2% |
| APLS | SELL · 10b5-1 | 2023-11-08 | 2023-11-09 | $47.27 | $567K | +6.5% | +29.2% | +43.9% |
| APLS | SELL · 10b5-1 | 2023-10-09 | 2023-10-10 | $40.38 | $969K | +5.1% | +5.0% | +54.8% |
| APLS | SELL · 10b5-1 | 2023-09-08 | 2023-09-11 | $42.87 | $1.0M | +14.1% | +9.0% | +45.3% |
| APLS | SELL · 10b5-1 | 2023-08-08 | 2023-08-09 | $23.66 | $284K | +30.4% | +72.2% | +95.9% |
| APLS | SELL · 10b5-1 | 2023-07-10 | 2023-07-11 | $84.55 | $1.0M | -60.5% | -69.0% | -50.9% |
| APLS | SELL · 10b5-1 | 2023-06-08 | 2023-06-09 | $91.35 | $1.1M | -4.3% | -4.3% | -52.5% |
| APLS | SELL · 10b5-1 | 2023-05-08 | 2023-05-09 | $92.39 | $1.1M | -0.7% | +0.7% | -73.6% |
| APLS | SELL · 10b5-1 | 2023-04-10 | 2023-04-11 | $78.21 | $1.9M | +7.8% | +10.7% | +8.3% |
| APLS | SELL | 2023-03-08 | 2023-03-10 | $63.79 | $765K | -0.5% | +28.2% | +46.6% |
| APLS | SELL | 2023-02-08 | 2023-02-10 | $54.45 | $653K | +31.0% | +22.6% | +73.3% |
| APLS | SELL | 2023-01-09 | 2023-01-10 | $46.08 | $553K | +3.7% | +8.3% | +61.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.